Clin2
NCT07603037Worth exploringNot yet recruiting

Blood pressure drugs and lung function in acute respiratory failure

Acute Respiratory Failure (ARF)HypertensionPulmonary Perfusion ImbalanceAortic Dissection (Subset)

Treatments studied

Part of Heart & circulation clinical trials.

This study tests whether two blood pressure medications (nicardipine and nitroglycerin) affect how well your lungs exchange oxygen and remove carbon dioxide. It uses a special chest monitor to see if these drugs improve lung function during breathing machine support.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
12 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have acute respiratory failure (your blood oxygen level is low) and need a breathing machine.
  • You are receiving blood pressure medication through an IV to keep your blood pressure stable.
  • You do not have a pacemaker, defibrillator, or other metal device in your chest.
  • You are not severely obese (BMI under 50) and do not have massive swelling under the skin.
  • You are not pregnant or breastfeeding, and you are not taking certain erectile dysfunction drugs like Viagra or Cialis.
  • You do not have conditions that make nitroglycerin unsafe, like severe anemia or increased pressure in the brain.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06741137Recruiting
Inhaled nitric oxide and prone positioning for ARDS

This trial is testing whether adding inhaled nitric oxide to lying on your stomach (prone position) can help people with severe lung failure (ARDS) who are on a ventilator. It uses a special monitor (EIT) to check lung function in real time.

Yangzhou, Jiangsu
NCT05801224Recruiting
Inhaled nitric oxide for lung injury in intensive care

This study tests whether giving inhaled nitric oxide gas helps improve lung function in patients on a breathing tube with mild to moderate acute lung injury (ARDS). Participants will receive standard care plus the study gas, and the team will use special imaging to see how the lungs respond.

Boston, Massachusetts
NCT07617298Not yet recruiting
Inhaled nitric oxide for lung function in ARDS patients on breathing support

This study tests whether inhaling nitric oxide gas can improve how well oxygen moves from the lungs into the blood in people with ARDS who are using noninvasive breathing support like a CPAP or high-flow nasal oxygen. It may help doctors understand if this treatment can improve lung function and potentially reduce the need for a breathing tube.

Shanghai
NCT07614438Not yet recruiting· Phase 2
Comparing blood pressure medications after pulmonary endarterectomy

This trial compares two medications, vasopressin and norepinephrine, to see which one better controls blood pressure in the lungs after surgery to remove blockages from the lung arteries. The goal is to find a treatment that keeps the lung blood pressure stable while minimizing side effects.

Le Plessis-Robinson
NCT07667829Not yet recruiting
Vasopressor drugs for pulmonary hypertension crisis

This trial tests whether three common blood pressure medicines (dopamine, norepinephrine, and epinephrine) can help people who are hospitalized with a sudden worsening of pulmonary hypertension, a condition of high blood pressure in the lungs. It aims to find a treatment that can stabilize patients during this dangerous time.

Beijing, Beijing Municipality
NCT07623590Recruiting
Finding the Best Lung Pressure Settings in Critically Ill Patients

This study tests two different methods to help doctors adjust breathing machine settings for patients with severe lung injury. The trial compares gentle chest/belly compressions with a special imaging technique to find the safest pressure levels.

Créteil

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.